Related Experiment Video
Updated: Feb 9, 2026

Induction of Accelerated Atherosclerosis in Mice: The "Wire-Injury" Model
Published on: August 25, 2020
Apoptotic cell induction of miR-10b in macrophages contributes to advanced atherosclerosis progression in ApoE-/-
Dongliang Wang1,2, Wenting Wang1, Weiqun Lin1
1Department of Nutrition, School of Public Health, Sun Yat-sen University, 74 Zhongshan Road II, Guangzhou, PR China.
Aims:
We previously found that miR-10b inhibits cholesterol efflux from thioglycollate-elicited mouse peritoneal macrophages through repressing ATP binding cassette transporter (ABCA1). Herein, we deciphered the mechanism underlying macrophage miR-10b expression and the role of miR-10b in atherosclerosis.
Methods And Results:
MiR-10b expression was increased in the arteries with advanced but not early atherosclerotic plaques of ApoE-/- mice. Free cholesterol-induced macrophage apoptotic cells (FC-AM) promoted miR-10b expression in mouse resident peritoneal macrophages (RPM) by up-regulation of Twist1/2 in a Mer receptor tyrosine kinase dependent manner. Surprisingly, antagomiR-10b de-repressed ABCA1 in RPM engulfing FC-AM but not in RPM alone or RPM-derived foam cells; systemic delivery of antagomiR-10b enhanced reverse cholesterol transport from RPM engulfing FC-AM but not from RPM or the foam cells in ApoE-/- mice. Mechanistically, RPM engulfing FC-AM possessed sufficient miR-10b functionally repressing ABCA1 expression, whereas RPM and foam cells had little miR-10b incompetently repressing ABCA1 expression. Notably, antagomiR-10b administration reduced advanced plaque size and also enhanced plaque stability in ApoE-/-mice, which were associated with increased plaque macrophage ABCA1 expression and reduced plaque apoptosis and inflammation. However, antagomiR-10b administration did not affect early atherosclerotic plaque formation in ApoE-/- mice.
Conclusion:
These data suggest that apoptotic cell induction of miR-10b in macrophages is important in advanced atherosclerosis progression.
Insights
Macrophage miR-10b, induced by apoptotic cells, promotes advanced atherosclerosis by inhibiting cholesterol efflux. Inhibiting miR-10b with antagomiR-10b reduces plaque size and improves stability in ApoE-/- mice.
Area of Science:
- Molecular Biology
- Cardiovascular Research
- Immunology
Background:
- MicroRNA-10b (miR-10b) previously shown to inhibit cholesterol efflux by repressing ATP binding cassette transporter A1 (ABCA1) in macrophages.
- Atherosclerosis is a chronic inflammatory disease characterized by plaque buildup in arteries.
Purpose of the Study:
- To elucidate the mechanism of macrophage miR-10b expression.
- To investigate the role of miR-10b in the progression of atherosclerosis.
Main Methods:
- Assessed miR-10b expression in atherosclerotic arteries of ApoE-/- mice.
- Investigated miR-10b induction by free cholesterol-induced macrophage apoptotic cells (FC-AM) in resident peritoneal macrophages (RPM).
- Utilized antagomiR-10b to inhibit miR-10b function in vitro and in vivo in ApoE-/- mice.
Main Results:
- miR-10b expression increased in advanced atherosclerotic plaques.
- FC-AM promoted miR-10b expression in RPM via Twist1/2 and Mer receptor tyrosine kinase.
- AntagomiR-10b de-repressed ABCA1, enhanced reverse cholesterol transport, reduced plaque size, and improved plaque stability in advanced atherosclerosis.
- miR-10b levels were critical for repressing ABCA1 in FC-AM-engulfing RPM.
Conclusions:
- Apoptotic cell-induced miR-10b in macrophages is a key driver of advanced atherosclerosis.
- Targeting miR-10b offers a potential therapeutic strategy for advanced atherosclerosis.
Related Concept Videos
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Atherosclerosis III: Management
Atherosclerosis I: Introduction
Binet's Contribution to Measures of Intelligence
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway

